|
BioScreening - organic compounds for screening
News: Grants and AwardsProfiling of Tumor Tissue Slices is Awarded Prize - Novel drug screening tool based on the Bionas® 2500 analyzing system wins silver medal in European business plan contest
Rostock, Germany, November 26, 2007 / b3c newswire / - Bionas GmbH, a specialist for in vitro profiling the metabolic activity of cells, announced that Prof. Pedro Mestres of the Saarland University (Homburg/Saar, Germany) has been awarded [...]
ERA-NET PathoGenoMics recognises outstanding PhD theses - Increasingly, disease-causing microorganisms are being analysed on a genetic level in the hope of identifying critical factors that might be therapeutically applicable. European research in this area is being promoted under the roof of the ERA-NET PathoGenoMics network. During the 3rd European Conference on Procaryotic Genomics, held from 7 to 10 October in Göttingen, Germany, [...]
FDA approves Merck’s Isentress for HIV - Oct 16, 2007 (Datamonitor via COMTEX) — MRK | charts | news | PowerRating — The FDA has granted Merck & Co.’s Isentress tablets accelerated approval for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to [...]
Nanion’s Technology Nominated for Presidential Innovation Award - Munich , Oct 11, 2007 :Â The planar patch clamp technology used in a family of automated electrophysiology products developed and marketed by Nanion Technologies GmbH in Munich , Germany , is among four technological and scientific innovations that have been nominated for this year’s Deutscher Zukunftspreis (German Future Award). The nomination of the project [...]
Portraitâ„¢ 630 Reagent Multi-spotter Wins Technology Prize at MipTec 10th Anniversary Conference in Basel, Switzerland - Sunnyvale, CA, May 22, 2007 - Portraitâ„¢ 630 Reagent Multi-spotter Wins Technology Prize at MipTec 10th Anniversary Conference in Basel, Switzerland
The European Laboratory Robotics Interest Group (ELRIG) has selected the Labcyte Portrait 630 reagent multi-spotter as the winner of its annual Technology Prize, awarded this year at the MipTec 10th Anniversary Conference, held May 8-11, [...]
KU Medical Center to lead $7.5-million male contraceptive research and drug development program - A researcher at the University of Kansas Medical Center has been awarded more than $7.5 million in funding from the National Institutes of Health to lead a team, including researchers at seven universities, in a collaborative effort to develop male contraceptives.
This five-year grant will establish the Interdisciplinary Center for Male Contraceptive Research and Drug [...]
Labcyte Awarded 28th U. S. Patent Describing Improved HTS Microplates for Low Volume Acoustic Transfer - Sunnyvale, CA, March 15, 2007 – Labcyte Inc. announces the issuance of U.S. Patent 7,185, 969 describing microplates used in high-throughput screening that have low electrical resistance. These plates are more easily electrically grounded than traditional plastic microplates and are more easily de-ionized.
“The trajectory of small droplets can be influenced by electric charges and [...]
Nanion continues opposition against Molecular Devices patent – “a precautionary measure” - Nanion Technologies GmbH, a supplier of automated, parallel patch-clamp systems based in Munich, Germany, today announced that they would appeal the decision of the European Patent Office (EPO) to uphold the disputed Molecular Devices patent EP 1,040,349.
The appeal is merely a precaution against problems with future developments in the field and it should be realized [...]
Frost & Sullivan Recognizes DiscoveRx’s Innovative Assay Technology for Drug Screening and Overall Achievements in Intact Cell-Based Assays - PALO ALTO, Calif., Sept. 7 /PRNewswire/ — Frost & Sullivan selected DiscoveRx Corp. as the recipient of the 2006 Frost & Sullivan Award for Technology Innovation for its development of the PathHunter(TM), an innovative protein trafficking platform technology. In its simplest format, this assay system allows users to monitor signaling pathways using translocation in [...]
Labcyte Awarded 27th U. S. Patent Describing Acoustic Transfer for the Preparation of Protein Microarrays - Labcyte Inc. has announced the issuance of U.S. Patent 7,090,333 describing the use of acoustic droplet ejection (ADE) for the preparation of microarrays of proteins and peptides.
ADE uses sound to move fluids eliminating all physical contact with the liquid being transferred.
This disposes of the need for pin tools, pipettes and nozzles that are currently used [...]
Euroscreen Awarded U.S. Patent on Human Nociceptin (ORL1) Receptor - Euroscreen SA today announced that it has been issued an U.S. patent that covers the use of an important human neurology drug target. The receptor, a G-protein-coupled receptor (GPCR) known as the human nociceptin (ORL1) receptor, is implicated in the control of some key neurological processes, such as pain perception, analgesia, and anxiety. Euroscreen’s patent [...]
Labcyte Certified as a Green Business - Sunnyvale, CA, July 18, 2006 – Labcyte Inc. today announced that it is one of the first high-tech manufacturing companies in Sunnyvale to be certified as a Green Business. The Green Business Program is a voluntary program that recognizes businesses that commit to full compliance with environmental regulations and take steps to prevent pollution, reduce [...]
Labcyte Issued 26th U. S. Patent Describing Reduction of Electrostatic Charge to Ensure Proper Volume Transfer and Trajectory - Sunnyvale, CA, July 11, 2006 – Labcyte Inc. announces the issuance of U.S. Patent 7,070,260. This patent describes the use of deionization of microplates and reservoirs to ensure improved precision and accuracy of acoustic droplet ejection (ADE) and other techniques employing the transfer of small fluid droplets. Plastic multi-well microplates such as those commonly [...]
Domantis First to Win UK Innovation in Drug Discovery & Development Award - CAMBRIDGE, U.K. and WALTHAM, Mass., July 12 /PRNewswire/ — Domantis, the human Domain Antibody (dAb) therapeutics company, is the first winner of the UK Innovation in Drug Discovery & Development Award, one of three new BioEntrepreneur Awards sponsored by London First and UK Trade & Investment.
The award recognizes the contribution Domantis has made to the [...]
Richard Ellson Receives the 2006 SBS PolyPops Foundation Award for Acoustic Dispensing Technology - Danbury, CT May, 2006 The Society for Biomolecular Sciences awarded Richard Ellson the 2006 SBS PolyPops Foundation Award for his work developing acoustic dispensing technology. Mr. Ellson, Chief Technical Officer for Labcyte Inc., Sunnyvale, California, used this technology in the Echo 550 and Echo 555 liquid handlers, which enables users to move liquids with sound. [...]
Labcyte CTO Ellson Awarded for Acoustic Dispensing Technology - Sunnyvale, CA, March 21, 2006 – Richard Ellson, Chief Technical Officer for Labcyte Inc., has been awarded the 2006 SBS PolyPops Foundation Award by the Society for Biomolecular Sciences for his work developing acoustic dispensing technology. This technology, used in the Echo 550 and Echo 555 liquid handlers, enables users to move liquids with sound. [...]
Nanion receives Bavarian Innovation Award 2005 - Munich, Germany – Octobre 2005 – The German nanobiotech company Nanion Technologies GmbH was recently awarded the Bavarian Innovation Award 2005 and is Bavarias company of the year (small/medium enterprise (SME)).
Nanion received the award for its chip-based patch clamp technique, which allows to perform sophisticated electrophysiological measurements from cells in an automated and parallel manner. [...]
Nanion Technologies receives German award for Nanosciences - Niels Fertig, CEO of Nanion Technologies GmbH (Munich), has won the 2005 NanoScience prize of the HanseNanoTec (Hamburg Competence Center for Nanotechnology) for his work on a chip-based measuring system for ion channels. Nanion Technologies developed a biochip that enables patch clamp recordings in an automated and parallel format. The prize was awarded on October [...]
LifePharms, Inc. Receives Approval for Phase II SBIR Grant for Cancer Research from NIH - GROTON, Conn. (Sept. 25, 2005) – LifePharms, Inc., has received approval for the second phase of a 2 year, $903,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health’s National Cancer Institute to continue development of its leading anti-cancer compound. The Phase I grant was used to identify promising anti-cancer compounds from [...]
Protected: Labcyte Receives 22nd Patent for Restoration of Fluid Volume and Composition Using Acoustics - There is no excerpt because this is a protected post.
|
|
